Literature DB >> 836652

Implantation of pure crystalline pellets of estradiol for conception control.

R B Greenblatt, R H Asch, V B Mahesh, J R Bryner.   

Abstract

Estradiol pellet implantation for contraception offers another alternative in conception control. The occurrence of only two pregnancies in 1,668 cycles (Pearl index: 1,42) reflects its efficacy. The advantages over oral contraceptives are: (1) absence of gastrointestinal symptoms, (2) minimal untoward effects, (3) no patient failure, and (4) convenience. Progressive stepdown in dose reduces the total amount of steroid used in long-term contraception. Contraceptive effect may not occur during the first month of implantation; adequate precaution should be taken. Because of the efficacy, minimal untoward side effects, and excellent patient acceptability, this regimen may be considered for contraception in developing countries and when other modalities are contraindicated.

Entities:  

Keywords:  Biology; Blood Pressure; Body Weight; Clinical Research; Contraception; Contraceptive Effectiveness; Contraceptive Implants; Contraceptive Methods; Endocrine System; Estradiol--administraction and dosage; Estradiol--side effects; Estrogens; Evaluation; Family Planning; Follicle Stimulating Hormone; Hormones; Luteinizing Hormone; Physiology; Progesterone; Research Methodology; Use-effectiveness

Mesh:

Substances:

Year:  1977        PMID: 836652     DOI: 10.1016/0002-9378(77)90447-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  5 in total

1.  Treatment of the premenstrual syndrome by subcutaneous estradiol implants and cyclical oral norethisterone: placebo controlled study.

Authors:  A L Magos; M Brincat; J W Studd
Journal:  Br Med J (Clin Res Ed)       Date:  1986-06-21

2.  Does constitutional hypotension exist?

Authors:  J Pemberton
Journal:  BMJ       Date:  1989-03-11

3.  Suppression of ovulation by transdermal oestradiol patches.

Authors:  N R Watson; J W Studd; A F Riddle; M Savvas
Journal:  BMJ       Date:  1988-10-08

4.  Treatment of menstrual migraine by oestradiol implants.

Authors:  A L Magos; K J Zilkha; J W Studd
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-11       Impact factor: 10.154

5.  Serum dopamine beta-hydroxylase activity in menstrual migraine.

Authors:  A Magos; M Brincat; K J Zilkha; J W Studd
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-04       Impact factor: 10.154

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.